C4 Therapeutics

Parachute over La Jolla California
Biotech

Less than a year in, BenevolentAI CEO is out—Chutes & Ladders

Less than a year in, BenevolentAI CEO is out. Deshaies descends from Amgen research perch. Sage’s reorg scrambles executive team.
Darren Incorvaia , Zoey Becker Oct 18, 2024 8:30am
milkshake ice cream diner dessert open for two cheers

Merck KGaA paying $16M to join C4's protein degrader hunt

Mar 4, 2024 10:18am
Graphic image of someone cutting off a row of stick figures symbolizing employees

C4 lays off 30% of staff in aftermath of halting cancer drug

Jan 10, 2024 5:24am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Merck offers up to $610M for one of C4’s protein degraders

Dec 12, 2023 10:30am
plan B fail reroute road path trail miss

C4 culls phase 1/2 cancer program after efficacy fail

Nov 1, 2023 11:29am
hawaii parasail ocean

Guth takes reins of Bayer’s US operations—Chutes & Ladders

Jun 23, 2023 9:30am